CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan ADMA Biologics, Inc. - ADMA CFD

    3.1304
    3.68%
    0.0292
    Rendah: 3.1304
    Tinggi: 3.2899
    Market Trading Hours* (UTC) Opens on Friday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0292
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.024874%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.002651%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 3.2501
    Open* 3.28
    1-Year Change* 83.24%
    Day's Range* 3.1304 - 3.2899
    52 wk Range 1.43-3.98
    Average Volume (10 days) 3.20M
    Average Volume (3 months) 51.55M
    Market Cap 713.12M
    P/E Ratio -100.00K
    Shares Outstanding 222.16M
    Revenue 154.08M
    EPS -0.33
    Dividend (Yield %) N/A
    Beta 0.93
    Next Earnings Date May 9, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Mar 29, 2023 3.2501 0.0700 2.20% 3.1801 3.2600 3.1801
    Mar 28, 2023 3.1803 -0.0996 -3.04% 3.2799 3.3597 3.1703
    Mar 27, 2023 3.2999 -0.0199 -0.60% 3.3198 3.4495 3.2899
    Mar 24, 2023 3.3198 0.0299 0.91% 3.2899 3.4096 3.2301
    Mar 23, 2023 3.1105 0.0997 3.31% 3.0108 3.1204 3.0107
    Mar 22, 2023 2.9809 -0.0697 -2.28% 3.0506 3.0905 2.9809
    Mar 21, 2023 3.0706 0.0300 0.99% 3.0406 3.1703 3.0406
    Mar 20, 2023 3.0507 -0.0299 -0.97% 3.0806 3.1005 2.9310
    Mar 17, 2023 3.0606 -0.0298 -0.96% 3.0904 3.1204 3.0207
    Mar 16, 2023 3.1105 0.0300 0.97% 3.0805 3.1703 3.0506
    Mar 15, 2023 3.1105 0.0001 0.00% 3.1104 3.1902 3.0806
    Mar 14, 2023 3.2002 -0.0099 -0.31% 3.2101 3.2600 3.1603
    Mar 13, 2023 3.1803 0.1696 5.63% 3.0107 3.2201 3.0008
    Mar 10, 2023 3.0806 -0.1594 -4.92% 3.2400 3.2600 3.0307
    Mar 9, 2023 3.2600 -0.1496 -4.39% 3.4096 3.4395 3.2102
    Mar 8, 2023 3.3896 0.0100 0.30% 3.3796 3.4495 3.3497
    Mar 7, 2023 3.3797 0.0200 0.60% 3.3597 3.4495 3.2998
    Mar 6, 2023 3.3398 -0.0697 -2.04% 3.4095 3.4295 3.2999
    Mar 3, 2023 3.3996 -0.0897 -2.57% 3.4893 3.4893 3.3697
    Mar 2, 2023 3.4395 -0.0698 -1.99% 3.5093 3.5392 3.4395

    ADMA Biologics, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total revenue 80.9426 42.2198 29.3491 16.9853 22.7606
    Revenue 80.9426 42.2198 29.3491 16.9853 22.7606
    Cost of Revenue, Total 79.7693 61.2914 39.5042 42.1946 29.1643
    Gross Profit 1.17329 -19.0716 -10.1552 -25.2094 -6.40376
    Total Operating Expense 139.316 106.143 80.7359 77.2742 63.2808
    Selling/General/Admin. Expenses, Total 55.1856 39.2209 28.0804 30.3085 24.5966
    Research & Development 3.64606 5.90701 2.34385 3.92612 6.22959
    Unusual Expense (Income) 0 -0.9918 9.9625 0 2.05561
    Operating Income -58.3737 -63.9231 -51.3868 -60.2889 -40.5202
    Interest Income (Expense), Net Non-Operating -13.0223 -11.6969 -8.19259 -5.32738 -3.22862
    Other, Net -0.25158 -0.12853 -0.22732 -0.12712 -0.01014
    Net Income Before Taxes -71.6476 -75.7486 -48.2793 -65.7434 -43.759
    Net Income After Taxes -71.6476 -75.7486 -48.2793 -65.7434 -43.759
    Net Income Before Extra. Items -71.6476 -75.7486 -48.2793 -65.7434 -43.759
    Net Income -71.6476 -75.7486 -48.2793 -65.7434 -43.759
    Income Available to Common Excl. Extra. Items -71.6476 -75.7486 -48.2793 -65.7434 -43.759
    Income Available to Common Incl. Extra. Items -71.6476 -75.7486 -48.2793 -65.7434 -43.759
    Diluted Net Income -71.6476 -75.7486 -48.2793 -65.7434 -43.759
    Diluted Weighted Average Shares 139.579 86.1451 54.3481 45.1889 22.896
    Diluted EPS Excluding Extraordinary Items -0.51331 -0.87931 -0.88833 -1.45486 -1.9112
    Diluted Normalized EPS -0.51331 -0.89083 -0.91713 -1.45486 -1.82142
    Depreciation / Amortization 0.71535 0.71535 0.84494 0.84494 1.23467
    Total Extraordinary Items 0
    Gain (Loss) on Sale of Assets 0 11.5274
    Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
    Total revenue 41.0901 33.905 29.1031 26.3829 20.6805
    Revenue 41.0901 33.905 29.1031 26.3829 20.6805
    Cost of Revenue, Total 31.4335 26.1356 25.441 22.8714 20.2952
    Gross Profit 9.65664 7.7694 3.66204 3.51149 0.38534
    Total Operating Expense 50.4069 43.0798 50.5881 39.5741 35.1176
    Selling/General/Admin. Expenses, Total 17.7526 15.8919 17.6742 15.7948 13.873
    Research & Development 1.04195 0.87339 0.62411 0.72899 0.77056
    Depreciation / Amortization 0.17884 0.17884 0.17884 0.17884 0.17884
    Operating Income -9.31673 -9.17474 -21.485 -13.1912 -14.4371
    Interest Income (Expense), Net Non-Operating -5.57313 -4.57075 -3.35597 -3.31343 -3.29442
    Other, Net -0.00964 -0.01942 -0.16688 -0.1448 0.01855
    Net Income Before Taxes -14.8995 -13.7649 -25.0079 -16.6494 -17.7129
    Net Income After Taxes -14.8995 -13.7649 -25.0079 -16.6494 -17.7129
    Net Income Before Extra. Items -14.8995 -13.7649 -25.0079 -16.6494 -17.7129
    Net Income -14.8995 -13.7649 -25.0079 -16.6494 -17.7129
    Income Available to Common Excl. Extra. Items -14.8995 -13.7649 -25.0079 -16.6494 -17.7129
    Income Available to Common Incl. Extra. Items -14.8995 -13.7649 -25.0079 -16.6494 -17.7129
    Diluted Net Income -14.8995 -13.7649 -25.0079 -16.6494 -17.7129
    Diluted Weighted Average Shares 196.384 196.353 195.872 181.267 133.77
    Diluted EPS Excluding Extraordinary Items -0.07587 -0.0701 -0.12767 -0.09185 -0.13241
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.07587 -0.0701 -0.09362 -0.09185 -0.13241
    Unusual Expense (Income) 0 0 6.66994 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 208.729 153.741 85.8204 44.5296 62.3416
    Cash and Short Term Investments 51.0891 55.9212 26.7521 22.7549 43.1076
    Cash & Equivalents 51.0891 55.9212 26.7521 22.7549 43.1076
    Short Term Investments
    Total Receivables, Net 28.5769 13.2373 3.46992 1.39244 3.88015
    Accounts Receivable - Trade, Net 28.5769 13.2373 3.46992 1.39244 3.88015
    Total Inventory 124.724 81.5356 53.0647 18.6162 12.6282
    Prepaid Expenses 4.33925 3.04647 2.53359 1.76616 1.22565
    Total Assets 276.253 207.673 127.091 88.8765 108.019
    Property/Plant/Equipment, Total - Net 58.1977 45.8523 33.1413 30.1157 30.4669
    Property/Plant/Equipment, Total - Gross 71.4696 54.7162 38.8663 33.5368 31.7528
    Accumulated Depreciation, Total -13.2718 -8.86394 -5.72496 -3.42103 -1.28592
    Other Long Term Assets, Total 4.0674 2.10698 1.44004 6.69725 6.83155
    Total Current Liabilities 30.3783 19.9474 14.0279 9.62505 9.44018
    Accounts Payable 12.4294 11.0737 9.17459 5.90039 5.92087
    Accrued Expenses 16.7941 8.73083 4.71047 3.58182 3.37648
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases
    Other Current Liabilities, Total 1.15482 0.14283 0.14283 0.14283 0.14283
    Total Liabilities 135.08 119.424 100.898 69.1061 67.6861
    Total Long Term Debt 94.8662 92.9689 83.1992 44.075 42.9709
    Long Term Debt 94.8662 92.9689 83.1992 44.075 42.9709
    Other Liabilities, Total 9.8356 6.50774 3.67047 15.406 15.275
    Total Equity 141.173 88.2494 26.1931 19.7704 40.3328
    Common Stock 0.01958 0.01049 0.00593 0.00464 0.00453
    Additional Paid-In Capital 553.266 428.704 290.904 236.203 191.022
    Retained Earnings (Accumulated Deficit) -412.113 -340.465 -264.717 -216.437 -150.694
    Total Liabilities & Shareholders’ Equity 276.253 207.673 127.091 88.8765 108.019
    Total Common Shares Outstanding 195.814 104.903 59.3184 46.3531 36.7255
    Other Current Assets, Total 0 1.5
    Goodwill, Net 3.52951 3.52951 3.52951 3.52951 3.52951
    Intangibles, Net 1.72877 2.44412 3.15947 4.00441 4.84935
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 239.8 208.729 174.785 171.355 177.277
    Cash and Short Term Investments 69.505 51.0891 34.4106 42.409 61.9657
    Cash & Equivalents 69.505 51.0891 34.4106 42.409 61.9657
    Total Receivables, Net 25.6296 28.5769 20.3926 23.5446 15.362
    Accounts Receivable - Trade, Net 25.6296 28.5769 20.3926 23.5446 15.362
    Total Inventory 139.146 124.724 114.123 99.6997 94.1462
    Prepaid Expenses 5.5193 4.33925 5.85905 5.70186 5.80261
    Total Assets 308.033 276.253 238.64 232.814 235.667
    Property/Plant/Equipment, Total - Net 60.3271 58.1977 55.0847 53.316 50.3729
    Property/Plant/Equipment, Total - Gross 75.0076 71.4696 67.2809 64.2715 60.2769
    Accumulated Depreciation, Total -14.6804 -13.2718 -12.1962 -10.9555 -9.90401
    Goodwill, Net 3.52951 3.52951 3.52951 3.52951 3.52951
    Intangibles, Net 1.54993 1.72877 1.90761 2.08645 2.26528
    Other Long Term Assets, Total 2.82575 4.0674 3.33351 2.52666 2.22278
    Total Current Liabilities 31.5665 30.3783 32.3372 18.1864 21.2057
    Accounts Payable 14.1151 12.4294 17.2828 6.16747 12.1529
    Accrued Expenses 14.2198 16.7941 13.0301 10.7303 8.14151
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 3.23159 1.15482 2.02432 1.28866 0.91137
    Total Liabilities 181.099 135.08 135.86 121.22 123.163
    Total Long Term Debt 138.423 94.8662 94.363 93.877 93.4127
    Long Term Debt 138.423 94.8662 94.363 93.877 93.4127
    Other Liabilities, Total 11.1099 9.8356 9.15999 9.15685 8.54454
    Total Equity 126.933 141.173 102.78 111.594 112.504
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.01964 0.01958 0.01383 0.01319 0.0123
    Additional Paid-In Capital 564.034 553.266 498.23 489.331 471.337
    Retained Earnings (Accumulated Deficit) -437.121 -412.113 -395.463 -377.75 -358.845
    Total Liabilities & Shareholders’ Equity 308.033 276.253 238.64 232.814 235.667
    Total Common Shares Outstanding 196.348 195.814 138.314 131.872 123.045
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line -71.6476 -75.7486 -48.2793 -65.7434 -43.759
    Cash From Operating Activities -112.369 -102.003 -76.1935 -62.6787 -37.2718
    Cash From Operating Activities 5.4955 3.94229 3.25815 3.4464 2.6923
    Non-Cash Items 5.46355 3.58462 2.33044 3.30681 4.07714
    Cash Interest Paid 11.1595 10.2676 8.11223 4.39997 2.29359
    Changes in Working Capital -51.6804 -33.7813 -33.5028 -3.68844 -0.28224
    Cash From Investing Activities -13.5113 -12.7247 -3.81184 -2.0956 15.2139
    Capital Expenditures -13.5113 -12.7267 -3.81184 -2.0956 -2.67633
    Other Investing Cash Flow Items, Total 0 0.002 0 17.8902
    Cash From Financing Activities 121.048 143.897 80.0026 42.9216 60.7506
    Financing Cash Flow Items -0.0616 -0.83 -10.9395 0 -3.44017
    Issuance (Retirement) of Stock, Net 121.144 131.209 48.4721 42.9578 39.2074
    Issuance (Retirement) of Debt, Net -0.0343 13.5179 42.47 -0.03628 24.9834
    Net Change in Cash -4.83203 29.169 -0.00272 -21.8527 38.6927
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -25.0079 -71.6476 -54.9982 -37.2852 -18.3799
    Cash From Operating Activities -26.0134 -112.369 -78.9037 -65.4914 -33.2291
    Cash From Operating Activities 1.59022 5.4955 3.97779 2.55562 1.22963
    Non-Cash Items 8.86246 5.46355 3.64236 2.50146 1.19026
    Cash Interest Paid 2.52599 11.1595 8.34697 5.53428 2.75196
    Changes in Working Capital -11.4582 -51.6804 -31.5257 -33.2632 -17.2691
    Cash From Investing Activities -2.84209 -13.5113 -9.8354 -7.04674 -2.57116
    Capital Expenditures -2.84209 -13.5113 -9.8354 -7.04674 -2.57116
    Other Investing Cash Flow Items, Total 0 0 0 0
    Cash From Financing Activities 47.2713 121.048 67.2286 59.0259 41.8448
    Financing Cash Flow Items -4.46973 -0.0616 -0.0616 -0.05931 -0.05931
    Issuance (Retirement) of Stock, Net 0 121.144 67.3157 59.1021 41.9125
    Issuance (Retirement) of Debt, Net 51.7411 -0.0343 -0.02551 -0.01686 -0.00836
    Net Change in Cash 18.4158 -4.83203 -21.5106 -13.5122 6.04456
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    BlackRock Institutional Trust Company, N.A. Investment Advisor 6.0714 13488055 1946140 2022-12-31 LOW
    Perceptive Advisors LLC Private Equity 5.3567 11900255 966868 2022-12-31 MED
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.9547 11007209 1583787 2022-12-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.8776 10835875 1545176 2022-12-31 LOW
    NWQ Investment Management Company, LLC Investment Advisor/Hedge Fund 4.7771 10612600 3727960 2021-12-31 LOW
    D. E. Shaw & Co., L.P. Hedge Fund 3.8299 8508409 2664613 2022-12-31 MED
    Stonepine Capital Management, LLC Investment Advisor/Hedge Fund 3.1239 6940000 1940000 2022-12-31 MED
    Magnetar Capital Partners LP Investment Advisor/Hedge Fund 2.7851 6187316 1815908 2022-12-31 HIGH
    AWM Investment Company, Inc. Investment Advisor/Hedge Fund 2.7076 6015000 1000000 2022-12-31 LOW
    Millennium Management LLC Hedge Fund 2.3843 5296781 3569778 2022-12-31 HIGH
    Nuveen Asset Management, LLC Investment Advisor/Hedge Fund 1.8471 4103514 -883582 2022-12-31 LOW
    Velan Capital Investment Management LP Investment Advisor/Hedge Fund 1.8005 4000000 -1269155 2022-12-31 MED
    Invesco Advisers, Inc. Investment Advisor 1.7531 3894678 813693 2022-12-31 LOW
    Aisling Capital, LLC Private Equity 1.6275 3615671 0 2022-04-15
    Nuveen LLC Pension Fund 1.5525 3448993 -267644 2022-12-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.5245 3386852 100723 2022-12-31 LOW
    Two Sigma Investments, LP Hedge Fund 1.337 2970124 1530127 2022-12-31 HIGH
    Altium Capital Management LP Investment Advisor/Hedge Fund 1.2919 2870000 -13710 2022-12-31 HIGH
    Morgan Stanley & Co. LLC Research Firm 1.2702 2821903 558990 2022-12-31 MED
    Caligan Partners, LP Hedge Fund 1.2046 2676093 -8217144 2022-12-31 MED

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    500K+

    Trader

    92K+

    Klien aktif per bulan

    $53M+

    Volume investasi per bulan

    $30M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Biopharmaceuticals

    C/O Adma Biologics, Inc.
    465 State Route 17
    07446

    Income Statement

    • Annual
    • Quarterly

    People also watch

    Oil - Crude

    74.40 Price
    +2.160% 1D Chg, %
    Biaya inap posisi Long -0.0170%
    Biaya inap posisi short -0.0049%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    BTC/USD

    28,179.10 Price
    -0.880% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    XRP/USD

    0.54 Price
    -2.690% 1D Chg, %
    Biaya inap posisi Long -0.0753%
    Biaya inap posisi short 0.0069%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.00459

    Gold

    1,980.49 Price
    +0.790% 1D Chg, %
    Biaya inap posisi Long -0.0180%
    Biaya inap posisi short 0.0098%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda